Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. In December interim phase 1/2 trial results showed ...

Electronic reminders to encourage older adults in Denmark to get vaccinated against flu may have unintentionally lowered ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

Starting this year, pharma giant Sanofi SNY markets Novavax’s COVID-19 vaccine and is also using it to develop novel COVID-19-influenza combination vaccines. Per the deal terms between the ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

Sinovac Biotech, a China-based biopharmaceutical company specializing in vaccine development, has been urged by shareholder ...

Novavax also earned global approvals for and commercialized its first vaccine ever for COVID-19, ramping up quickly to meet ...

Research offering unprecedented insights into global vaccine distribution patterns has found significant disparities in COVID ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.